Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,057 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Exercise / conversion · Acquired 20,000 · Balance 36,057 |
| Common StockSEC Table I · non-derivative | Direct | 16,057 |
Reported balance
After 2026-10-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-01 · Sale · Disposed 20,000 · Balance 16,057 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2: This transaction was executed in multiple trades at prices ranging from $18.28 USD to $18.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.68 · Expires 2027-03-01 | Direct | 66,260 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 20,000 · Balance 66,260 F5: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 81,073 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 81,073 F4: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025.
F2: This transaction was executed in multiple trades at prices ranging from $18.28 USD to $18.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
F5: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 21:54 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001035986-26-000007 · primarydocument.xml · derivative · entry 4 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,260 Underlying: Common Stock · 20,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 21:54 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 20,000 | $18.47 | $369,400.00 |
DisclosureSEC source: 0001035986-26-000007 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,057 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.28 USD to $18.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 21:54 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 20,000 | $4.68 | $93,600.00 |
DisclosureSEC source: 0001035986-26-000007 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,633 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · derivative · entry 7 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,260 Underlying: Common Stock · 18,633 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,367 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · derivative · entry 6 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,893 Underlying: Common Stock · 1,367 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,367 | $18.91 | $25,847.24 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · nonDerivative · entry 4 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,057 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.6450 to $19.6449, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 18,633 | $18.91 | $352,312.76 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · nonDerivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,424 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.6450 to $19.6449, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 1,367 | $4.68 | $6,397.56 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 23:26 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 18,633 | $4.68 | $87,202.44 |
DisclosureSEC source: 0001035986-26-000006 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 22:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001035986-26-000005 · primarydocument.xml · derivative · entry 4 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,260 Underlying: Common Stock · 20,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 22:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 20,000 | $18.46 | $369,214.00 |
DisclosureSEC source: 0001035986-26-000005 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,057 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.20 to $18.93, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 22:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 20,000 | $4.68 | $93,600.00 |
DisclosureSEC source: 0001035986-26-000005 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2026 Filed Jun 8, 2026 21:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,575 | $15.25 | $54,505.17 |
DisclosureSEC source: 0001035986-26-000004 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,057 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.085 USD to $15.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 21:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 10,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001035986-26-000004 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,114 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. Read SEC document |
| May 04, 2026 Filed May 5, 2026 21:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 337 | $13.15 | $4,431.82 |
DisclosureSEC source: 0001035986-26-000003 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,157 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.00 USD to $13.23 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 23:11 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 337 | $16.42 | $5,532.09 |
DisclosureSEC source: 0001035986-26-000002 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,970 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.35 USD to $16.56 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 9,491 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 23:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 20,000 | $21.28 | $425,506.00 |
DisclosureSEC source: 0001035986-26-000001 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 80,115 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.84 to $21.84, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 14:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,241 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001035986-25-000006 · primarydocument.xml · derivative · entry 4 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,241 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 14:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 18,759 | $19.33 | $362,605.84 |
DisclosureSEC source: 0001035986-25-000006 · primarydocument.xml · nonDerivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 110,115 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.13 to $19.85, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F4 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 14:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,241 | $19.33 | $23,988.16 |
DisclosureSEC source: 0001035986-25-000006 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,307 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.13 to $19.85, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 10,307 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 14:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 1,241 | $4.32 | $5,361.12 |
DisclosureSEC source: 0001035986-25-000006 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 56,852 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · derivative · entry 7 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,241 Underlying: Common Stock · 56,852 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,148 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · derivative · entry 6 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,093 Underlying: Common Stock · 23,148 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 56,852 | $18.95 | $1,077,345.40 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · nonDerivative · entry 4 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,307 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. F2 · balance_after: Includes 10,307 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 56,852 | $4.32 | $245,600.64 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · nonDerivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 23,148 | $4.32 | $99,999.36 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 23,148 | $18.95 | $438,654.60 |
DisclosureSEC source: 0001035986-25-000005 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,307 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 23:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 293 | $14.80 | $4,337.51 |
DisclosureSEC source: 0001035986-25-000004 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,831 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.68 USD to $15.03 USD; the price reported above reflects the weighted average sale price. . The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 10,307 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 293 | $17.37 | $5,090.67 |
DisclosureSEC source: 0001562180-25-005671 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,647 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.36 USD to $17.39 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 11,124 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,377 | $19.05 | $64,334.89 |
DisclosureSEC source: 0001562180-25-004613 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,354 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.90 USD to $19.29 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 11,940 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004613 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,211 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. Read SEC document |
| May 01, 2025 Filed May 2, 2025 21:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 336 | $13.78 | $4,628.40 |
DisclosureSEC source: 0001562180-25-003529 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,536 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.69 USD to $13.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 12,056 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:16 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,619 | $16.77 | $27,151.60 |
DisclosureSEC source: 0001562180-25-001485 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,191 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.36 USD to $16.945 USD; the price reported above reflects the weighted average sale price. F3 · balance_after: Includes 12,872 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:09 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 337 | $16.51 | $5,562.39 |
DisclosureSEC source: 0001562180-25-000976 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,290 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.38 USD to $16.55 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F4 · balance_after: Includes 16,810 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 22:13 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,609 | $12.43 | $20,001.32 |
DisclosureSEC source: 0001562180-24-007841 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,431 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.33 USD to $13.06 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 17,627 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 23:19 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 341 | $13.55 | $4,620.55 |
DisclosureSEC source: 0001562180-24-007575 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,040 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F3 · balance_after: Includes 21,565 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 23:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,580 | $13.84 | $21,867.36 |
DisclosureSEC source: 0001562180-24-006412 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,212 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.77 USD to $14.09 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 22,381 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:38 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 343 | $14.32 | $4,912.48 |
DisclosureSEC source: 0001562180-24-006068 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,792 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.20 USD to $14.50 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 26,319 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 21:52 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005333 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,135 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date F2 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F3 · balance_after: Includes 27,135 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2024 Filed Jun 13, 2024 00:36 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 341 | $12.99 | $4,430.20 |
DisclosureSEC source: 0001562180-24-005023 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,814 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.93 USD to $13.07 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F4 · balance_after: Includes 18,344 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 16, 2024 Filed May 18, 2024 00:05 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,581 | $15.13 | $23,922.27 |
DisclosureSEC source: 0001562180-24-004172 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,512 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.06 USD to $15.22 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F4 · balance_after: Includes 19,155 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:32 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 343 | $14.54 | $4,985.54 |
DisclosureSEC source: 0001562180-24-003709 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,566 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.45 USD to $14.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F4 · balance_after: Includes 23,093 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,088 | $20.96 | $22,799.04 |
DisclosureSEC source: 0001562180-24-001540 · primarydocument.xml · nonDerivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,223 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 23,909 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,700 | $20.96 | $35,623.50 |
DisclosureSEC source: 0001562180-24-001540 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,311 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:21 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,372 | $20.96 | $28,750.26 |
DisclosureSEC source: 0001562180-24-001540 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,011 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 00:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 335 | $20.30 | $6,799.43 |
DisclosureSEC source: 0001562180-24-001069 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,383 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.17 USD to $20.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 35,420 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,514 | $17.68 | $26,774.94 |
DisclosureSEC source: 0001562180-23-007806 · primarydocument.xml · nonDerivative · entry 3 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,718 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.18 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Includes 36,236 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,495 | $17.68 | $79,486.43 |
DisclosureSEC source: 0001562180-23-007806 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,232 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.18 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 23:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,956 | $17.71 | $34,636.85 |
DisclosureSEC source: 0001562180-23-007806 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,727 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.18 USD to $17.86 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2023 Filed Nov 7, 2023 00:12 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 406 | $17.52 | $7,113.40 |
DisclosureSEC source: 0001562180-23-007575 · primarydocument.xml · nonDerivative · entry 2 DUNN JEFFREY W · CIK 0001035986 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,683 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $17.35 USD to $17.61 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F5 · balance_after: Includes 52,272 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.